CSHCN 2008 > Physician > Benefits and Limitations

24.3.21.1 Cytopathology Studies (Gynecological, Pap Smears)

Pap smear for early detection of cancer is a benefit of the CSHCN Services Program.

Procurement and handling of the Pap smear are considered part of the E/M of the client and are not reimbursed separately. Physicians interpreting a cytopathology specimen (Pap smear) must report the POS according to where the cytopathology specimen is interpreted (office [POS 1], inpatient [POS 3], outpatient [POS 5], or independent lab [POS 6]).

Because of the technical nature of processing and interpreting a Pap smear or specimen for cytopathology, pathologists are the only physician specialty reimbursed for these services.

Refer to: Chapter 19, "Laboratory Services," beginning on page 19-6, for additional information concerning coding and reimbursement for gynecological cytopathology studies.